Texas § 33.002 DETECTION AND TREATMENT PROGRAM ESTABLISHED.

Texas Statutes

§ 33.002 — DETECTION AND TREATMENT PROGRAM ESTABLISHED.

Texas § 33.002

Code HSHealth and Safety Code

This text of Texas § 33.002 (DETECTION AND TREATMENT PROGRAM ESTABLISHED.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Health and Safety Code Code Ann. § 33.002 (2026).

Text

Sec. 33.002. DETECTION AND TREATMENT PROGRAM ESTABLISHED.

(a)The department shall carry out a program to combat morbidity, including intellectual disability, and mortality in persons who have Duchenne muscular dystrophy, phenylketonuria, other heritable diseases, or hypothyroidism.

(b)The executive commissioner shall adopt rules necessary to carry out the program, including a rule specifying other heritable diseases covered by this chapter.

(c)The department shall establish and maintain a laboratory to:

(1)conduct experiments, projects, and other activities necessary to develop screening or diagnostic tests for the early detection of Duchenne muscular dystrophy, phenylketonuria, other heritable diseases, and hypothyroidism;

(2)develop ways and means or discover methods to be used to p

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 33.002. DETECTION AND TREATMENT PROGRAM ESTABLISHED. (a) The department shall carry out a program to combat morbidity, including intellectual disability, and mortality in persons who have Duchenne muscular dystrophy, phenylketonuria, other heritable diseases, or hypothyroidism.
(b) The executive commissioner shall adopt rules necessary to carry out the program, including a rule specifying other heritable diseases covered by this chapter.
(c) The department shall establish and maintain a laboratory to:
(1) conduct experiments, projects, and other activities necessary to develop screening or diagnostic tests for the early detection of Duchenne muscular dystrophy, phenylketonuria, other heritable diseases, and hypothyroidism;
(2) develop ways and means or discover methods to be used to prevent or treat Duchenne muscular dystrophy, phenylketonuria, other heritable diseases, and hypothyroidism; and
(3) serve other purposes considered necessary by the department to carry out the program.

Legislative History

Amended by Acts 1991, 72nd Leg., ch. 14, Sec. 8, eff. Sept. 1, 1991. Amended by: Acts 2015, 84th Leg., R.S., Ch. 1 (S.B. 219 ), Sec. 3.0099, eff. April 2, 2015. Acts 2023, 88th Leg., R.S., Ch. 30 (H.B. 446 ), Sec. 6.02, eff. September 1, 2023. Acts 2025, 89th Leg., R.S., Ch. 50 (S.B. 1044 ), Sec. 3, eff. September 1, 2025.